News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
130 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
2 (104)
3 (173)
4 (173)
5 (128)
6 (1)
7 (23)
8 (258)
9 (151)
10 (98)
11 (90)
12 (52)
13 (1)
14 (1)
15 (70)
16 (158)
17 (130)
18 (132)
19 (69)
20 (4)
21 (3)
22 (130)
23 (153)
24 (124)
25 (141)
26 (79)
27 (1)
28 (1)
29 (133)
30 (155)
31 (147)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Policy
FDA Slaps Warning on San Diego’s Imprimis Over Eye Drug Advertising
The Dec. 21 letter to San Diego-based Imprimis was posted on the FDA’s website on Tuesday.
January 17, 2018
·
1 min read
Business
Help Wanted: Amazon Seeks Health Privacy Expert for ‘New Initiative’
The company could be hoping the new hire will provide a consultative resource for all health-care regulatory issues.
January 17, 2018
·
1 min read
Business
Watch Out: Cambridge Biotech Makes a Comeback
After a two year absence, Aveo returned to the halls of the key event with a drug newly approved for use in Europe and possibly poised for approval in the U.S.
January 17, 2018
·
2 min read
·
Alex Keown
BioCapital
The Biggest Winners and Losers of JPM 2018
With the J.P. Morgan Healthcare Conference now over, some analysts are looking back and picking out the “winners and losers” from the conference.
January 17, 2018
·
3 min read
·
Alex Keown
Pharm Country
4 Up-and-Coming New York Biotech Startups to Watch Out For
The BAAC Academy awarded four startup biotech companies with $40,000 in cash and services.
January 17, 2018
·
2 min read
·
Mark Terry
Deals
Juno Explodes on Celgene Takeover Rumors
The rumors have caused Juno’s stock to rocket more than 50 percent to $68.80 in premarket trading.
January 17, 2018
·
3 min read
·
Mark Terry
Why Investors Should Avoid Israeli Biotechs Like the Plague
An online comment can spur some serious discussion.
January 17, 2018
·
2 min read
·
Alex Keown
Deals
Chinese Bidders Circle Johnson & Johnson’s $4B+ Diabetes Biz
Chinese interest in the J&J unit comes as the market for diabetes care in China is expected to grow rapidly.
January 17, 2018
·
1 min read
Drug Development
How This Little Biopharma Could Beat Amgen, Teva to the Migraine Finish Line
On Jan. 8, Alder BioPharma announced that its eptinezumab met its primary endpoint in its Phase III PROMISE 2 clinical trial for preventing migraine.
January 17, 2018
·
2 min read
·
Mark Terry
Deals
Boston’s resTORbio Sets Terms for $85M IPO
resTORbio is developing novel therapies to improve immune function in the elderly.
January 17, 2018
·
1 min read
1 of 13
Next
